<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine whether <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> other than <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anticardiolipin are associated with recurrent pregnancy loss </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Sera from three groups of women were studied: 1) 147 women with recurrent pregnancy loss but no clinical signs or symptoms of <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> who tested negative for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and medium-to-high levels of immunoglobulin G anticardiolipin antibodies; 2) 104 healthy, fertile controls of similar age and gravidity; and 3) 43 women with well-characterized <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Serum antibody binding against six <z:chebi fb="1" ids="16247">phospholipids</z:chebi> (<z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, <z:chebi fb="0" ids="16337">phosphatidic acid</z:chebi>, phosphatidylserine, <z:chebi fb="0" ids="49183">phosphatidylcholine</z:chebi>, <z:chebi fb="0" ids="16038">phosphatidylethanolamine</z:chebi>, and phosphatidylinositol) was determined using enzyme-linked immunoassays, and results were normalized using an anticardiolipin standard </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Twenty-six (18%) women with recurrent pregnancy loss and nine (9%) controls tested positive (above the 99th percentile) for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Sera from five (3.4%) women with recurrent pregnancy loss and four (3.8%) controls demonstrated binding to <z:chebi fb="0" ids="16247">phospholipid</z:chebi> antigens other than <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, binding to <z:chebi fb="0" ids="16247">phospholipid</z:chebi> antigens was demonstrated in sera from more than 90% of women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Among women testing positive for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, the median positive value for women in the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> group was significantly higher than for those with recurrent pregnancy loss or <z:mpath ids='MPATH_458'>normal</z:mpath> fertile controls </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Women with recurrent pregnancy loss are no more likely than fertile controls to have elevated levels of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> once <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, anticardiolipin, and an obvious clinical history of <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> have been excluded </plain></SENT>
<SENT sid="8" pm="."><plain>Testing for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> other than <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anticardiolipin is not clinically useful in the evaluation of recurrent pregnancy loss </plain></SENT>
</text></document>